Amarin Commemorates National Triglycerides Day on March 28
March 27 2018 - 4:30PM
Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical
company focused on the commercialization and development of
therapeutics to improve cardiovascular health, is proud to
support and participate in the first annual National Triglycerides
Day on March 28th. This awareness day calls attention to the
importance of knowing triglyceride levels and the steps we can take
to live healthier lives such as diet and exercise.
Amarin would like to commend recognition of National
Triglycerides Day by patient advocacy groups and professional
societies from a variety of therapeutic areas who represent
patients and healthcare professionals dedicated to improving and
advancing patient care, including:
American College of Cardiology (ACC)American
Pharmacists Association (APhA)American Society for Preventive
Cardiology (ASPC)DiabetesSistersEndocrine SocietyHormone Health
NetworkMetabolic Endocrine Education Foundation (MEEF)National
Kidney Foundation (NKF)Preventive Cardiovascular Nurses Association
(PCNA)Vascular Biology Working Group (VBWG)
Triglycerides are a type of fat (lipid) found in
the blood. The liver makes triglycerides. Many of the foods
eaten contain triglycerides. After eating, any extra calories that
the body doesn’t need right away are converted into triglycerides.
These fatty substances are stored in fat cells. They are later
released and circulated through the bloodstream to be used as
energy by cells. But, as with “bad” cholesterol (LDL-C), too much
can be harmful. Most dietary fats are triglycerides.1 High
triglycerides are associated with cardiovascular risk, even in
people with well-controlled LDL-C.2, 3, 4, 5
Normal triglyceride levels are generally less
than 150 mg/dL; borderline high levels are between 150 and 199
mg/dL; high levels are between 200 and 499 mg/dL; and very high
levels are 500 mg/dL and over.1
Patients and healthcare professionals need to
know about the hidden risks associated with high triglycerides.
National Triglycerides Day is an important opportunity to encourage
patients to learn more about their triglyceride levels and to take
action towards living a healthy life, starting with talking to
their healthcare professionals.
About Amarin
Amarin Corporation plc is a biopharmaceutical
company focused on the commercialization and development of
therapeutics to improve cardiovascular health. Amarin's
product development program leverages its extensive experience in
lipid science and the potential therapeutic benefits of
polyunsaturated fatty acids. For more information about
Amarin visit www.amarincorp.com.
Availability of Other Information About
Amarin
Investors and others should note that Amarin
communicates with its investors and the public using the company
website (http://www.amarincorp.com/), the investor relations
website (http://investor.amarincorp.com/), including but not
limited to investor presentations and investor FAQs, Securities and
Exchange Commission filings, press releases, public conference
calls and webcasts. The information that Amarin posts on
these channels and websites could be deemed to be material
information. As a result, Amarin encourages investors, the
media, and others interested in Amarin to review the information
that is posted on these channels, including the investor relations
website, on a regular basis. This list of channels may be
updated from time to time on Amarin’s investor relations website
and may include social media channels. The contents of
Amarin’s website or these channels, or any other website that may
be accessed from its website or these channels, shall not be deemed
incorporated by reference in any filing under the Securities Act of
1933.
References
1 Cardiosmart.org. Very High Triglycerides. Available at:
https://www.cardiosmart.org/Heart-Conditions/High-Cholesterol/High-Cholesterol-Home/Very-High-Triglycerides.
2 Budoff M. Triglycerides and triglyceride-rich
lipoproteins in the causal pathway of cardiovascular disease. Am J
Cardiol. 2016;118:138-145.
3 Toth PP, Granowitz C, Hull M, et al. High triglycerides
increase cardiovascular events, medical costs, and resource
utilization in a real-world analysis of statin-treated patients
with high cardiovascular risk and well-controlled low-density
lipoprotein cholesterol [abstract]. Circulation.
2017;136(suppl):A15187.
4 Nordestgaard BG. Triglyceride-rich lipoproteins and
atherosclerotic cardiovascular disease - New insights from
epidemiology, genetics, and biology. Circ Res.
2016;118:547-563.
5 Nordestgaard BG, Varbo A. Triglycerides and cardiovascular
disease. Lancet. 2014; 384: 626–635.
Amarin Contact Information
Investor Relations:Elisabeth Schwartz Investor Relations and
Corporate Communications Amarin Corporation plc In U.S.: +1
(908) 719-1315 investor.relations@amarincorp.com Lee M. Stern Trout
Group In U.S.: +1 (646) 378-2992 lstern@troutgroup.com
Media Inquiries: Kristie Kuhl Finn Partners In U.S.: +1 (212)
583-2791 Kristie.kuhl@finnpartners.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024